Sign In
Buy PRPO
$21.65
+0.460 (+2.17%)
At Close: Jul 31, 2026
Precipio Announces its Q3-2025 Financial Results
04:30pm, Friday, 14'th Nov 2025
Over $450,000 Adjusted EBITDA and $275,000 positive operating cash flow for the quarter Over $450,000 Adjusted EBITDA and $275,000 positive operating cash flow for the quarter
Precipio Announces Q3-2025 Shareholder Update Call
05:00pm, Tuesday, 04'th Nov 2025
NEW HAVEN, Conn., Nov. 04, 2025 (GLOBE NEWSWIRE) -- Specialty cancer diagnostics company Precipio, Inc. (NASDAQ: PRPO), will be hosting its Q3-2025 corporate update call on November 17th, 2025 at 5:0
Precipio, Inc. (PRPO) Q2 2025 Earnings Call Transcript
09:03pm, Thursday, 14'th Aug 2025
Precipio, Inc. (NASDAQ:PRPO ) Q2 2025 Earnings Conference Call August 14, 2025 5:00 PM ET Company Participants Ilan Danieli - Founder, President, CEO & Director Operator Welcome to the Precipio Q2 202
Precipio Announces its Q2-2025 Financial Results
05:00pm, Wednesday, 13'th Aug 2025
NEW HAVEN, Conn., Aug. 13, 2025 (GLOBE NEWSWIRE) -- Specialty cancer diagnostics company Precipio, Inc. (NASDAQ: PRPO) , filed its 10-Q report today.
Precipio Announces Q2-2025 Shareholder Update Call
04:30pm, Thursday, 31'st Jul 2025
NEW HAVEN, Conn., July 31, 2025 (GLOBE NEWSWIRE) -- Specialty cancer diagnostics company Precipio, Inc. (NASDAQ: PRPO), will be hosting its Q2-2025 corporate update call on August 14th, 2025 at 5:00
Precipio Enters Into Agreement With Warrant Holder To Exercise Majority Of Warrants As Cashless
04:30pm, Friday, 11'th Jul 2025
NEW HAVEN, Conn., July 11, 2025 (GLOBE NEWSWIRE) -- Specialty cancer diagnostics company Precipio, Inc. (NASDAQ: PRPO) has entered into an agreement with its largest warrant holder, amending the
Precipio, Inc. (PRPO) Q1 2025 Earnings Call Transcript
06:02pm, Thursday, 15'th May 2025
Precipio, Inc. (PRPO) Q1 2025 Earnings Call Transcript
Precipio Announces its Q1-2025 Financial Results
05:00pm, Wednesday, 14'th May 2025
NEW HAVEN, Conn., May 14, 2025 (GLOBE NEWSWIRE) -- Specialty cancer diagnostics company Precipio, Inc. (NASDAQ: PRPO) , filed its 10-Q report today.
Precipio Announces Q1-2025 Shareholder Update Call
05:00pm, Thursday, 01'st May 2025
NEW HAVEN, Conn., May 01, 2025 (GLOBE NEWSWIRE) -- Specialty cancer diagnostics company Precipio, Inc. (NASDAQ: PRPO) , will be hosting its Q1-2025 corporate update call on May 15th, 2025 at 5:00
Precipio, Inc. (PRPO) Q4 2024 Earnings Call Transcript
10:50pm, Monday, 31'st Mar 2025
Precipio, Inc. (NASDAQ:PRPO ) Q4 2024 Earnings Conference Call March 31, 2025 5:00 PM ET Company Participants Ilan Danieli - Chief Executive Officer Conference Call Participants Operator Welcome to th
Precipio Announces Q4 and year-end 2024 Shareholder Update Call
05:00pm, Monday, 17'th Mar 2025
NEW HAVEN, Conn., March 17, 2025 (GLOBE NEWSWIRE) -- Specialty cancer diagnostics company Precipio, Inc. (NASDAQ: PRPO), will be hosting its Q4 and year end 2024 corporate update call on March 31st,
Precipio Achieves Key Q4-2024 Financial Goals: Positive Adjusted EBITDA and Positive Cash Flow (unaudited)
09:30am, Tuesday, 25'th Feb 2025
Both metrics demonstrate the ability to achieve financial independence Both metrics demonstrate the ability to achieve financial independence
Precipio grants senior management performance-based awards instead of traditional time-vested ESOPs
05:00pm, Thursday, 16'th Jan 2025
NEW HAVEN, Conn., Jan. 16, 2025 (GLOBE NEWSWIRE) -- Specialty cancer diagnostics company Precipio, Inc. (NASDAQ: PRPO) , announced that options granted to senior management on January 14 would ve
Two Smaller Companies Worthy of Your "Attention"
03:37pm, Monday, 25'th Nov 2024
Here we highlight a small cap and a microcap with Zacks Outperform ratings.
Precipio, Inc. (PRPO) Q3 2024 Earnings Call Transcript
06:16pm, Monday, 18'th Nov 2024
Precipio, Inc. (NASDAQ:PRPO ) Q3 2024 Earnings Conference Call November 18, 2024 5:00 PM ET Company Participants Ilan Danieli - CEO Conference Call Participants Operator Good day. Welcome to the Preci
